CORVUS PHARMACEUTICALS INC. - COMMON STOCK
5.3300
10-يناير-25 16:45:00
15 متأخرة بدقائق
الأسهم
-0.3200
-5.66%
نطاق اليوم
5.2600 - 5.5750
ISIN
N/A
المصدر
NASDAQ
-
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial Results
01 نوفمبر 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
27 أكتوبر 2021 16:05:01 بحسب Nasdaq GlobeNewswire
-
22 سبتمبر 2021 06:00:00 بحسب Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
07 سبتمبر 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China
16 أغسطس 2021 17:00:00 بحسب Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
02 أغسطس 2021 16:05:01 بحسب Nasdaq GlobeNewswire
-
15 يوليو 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
25 مايو 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Completes Sale of $10 Million Through Its ATM Program
05 مايو 2021 09:00:01 بحسب Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
29 أبريل 2021 16:05:01 بحسب Nasdaq GlobeNewswire
-
25 مارس 2021 08:30:00 بحسب Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
05 مارس 2021 08:30:00 بحسب Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
17 فبراير 2021 16:10:00 بحسب Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12 فبراير 2021 09:00:00 بحسب Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
11 فبراير 2021 16:01:00 بحسب Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19
04 فبراير 2021 07:30:00 بحسب Nasdaq GlobeNewswire